{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:41:17Z","timestamp":1786650077607,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cisplatin is one of the anticancer drugs used for head and neck cancers. Although some studies have shown that cisplatin can cause ototoxicity, periodic audiometric assessments have not been extensively studied in the Indian rural population. Hence, this study has been undertaken to evaluate the effects of cisplatin on hearing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Fifty-nine patients with squamous cell carcinomas of head and neck, who received cisplatin chemotherapy, were recruited. Serum creatinine, blood urea, serum proteins, and audiometry were assessed before and after the first, second, and third chemotherapy cycle. The cochleotoxic effect of cisplatin was assessed by pure tone audiometry. Hearing loss was graded accordingly. All patients were administered a quality of life questionnaire at baseline and at the end of the third cycle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Hearing loss was observed in 12 patients at speech frequencies and those at higher frequencies were 12 (4000 Hz), 18 (6000 Hz), and 28 (8000 Hz). The hearing loss was symmetrical, sensorineural, and showed a strong correlation with the low serum albumin levels at the end of the third cycle. Dizziness was seen in eight patients, at the end of the study. The commonly observed adverse effects were nausea, vomiting, hair loss, fatigue, and tinnitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The studies have shown hearing loss in higher frequencies, but in our study, we have observed hearing loss at speech frequency in 22.2% of patients receiving cisplatin, who also had low serum albumin levels. Periodic audiometric monitoring and serum albumin level may be helpful to provide timely intervention to prevent further hearing loss and deterioration in the quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0973-1482.188426","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T09:03:38Z","timestamp":1531991018000},"page":"1099-1104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study"],"prefix":"10.4103","volume":"14","author":[{"given":"Balamurali","family":"Kalyanam","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sarala","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Azeem Mohiyuddin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Diwakar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJMsa0707719","article-title":"A nationally representative case-control study of smoking and death in India","volume":"358","author":"Jha","year":"2008","journal-title":"N Engl J Med"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-3284-1-17","article-title":"Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: A single-institution experience","volume":"1","author":"Gupta","year":"2009","journal-title":"Head Neck Oncol"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0030-6665(20)30766-0","article-title":"Ototoxicity of chemotherapeutic agents","volume":"26","author":"Schweitzer","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF03008019","article-title":"Study of the effects of chemotherapy on auditory function","volume":"57","author":"Dutta","year":"2005","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"Suppl 3","key":"R6-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2010-S3-01","article-title":"A new look at induction chemotherapy in locally advanced head and neck cancer","volume":"15","author":"Vermorken","year":"2010","journal-title":"Oncologist"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/07347330903438917","article-title":"Cancer patients' and partners' psychological distress and quality of life: Influence of gender role","volume":"28","author":"Pikler","year":"2010","journal-title":"J Psychosoc Oncol"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1200\/jco.2005.23.16_suppl.5549","article-title":"Serum albumin as an independent prognositic indicator in patients with advanced head and neck cancer treated with concurrent chemoradiotheapy","volume":"23","author":"Shin","year":"2005","journal-title":"J Clin Oncol"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1288\/00005537-198808000-00014","article-title":"Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing","author":"Kopelman","year":"1988","journal-title":"Laryngoscope"},{"key":"R10-20260109","first-page":"1359","article-title":"Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum (II) in man","volume":"62","author":"Patton","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archotol.1993.01880180081015","article-title":"High-frequency monitoring for early detection of cisplatin ototoxicity","volume":"119","author":"Fausti","year":"1993","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bcp.2004.01.010","article-title":"Protection against cisplatin ototoxicity by adenosine agonists","volume":"67","author":"Whitworth","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"R13-20260109","first-page":"513","article-title":"Effect of protective agents against cisplatin ototoxicity","volume":"21","author":"Rybak","year":"2000","journal-title":"Am J Otol"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archotol.1994.01880290051009","article-title":"Risk factors for ototoxicity due to cisplatin","volume":"120","author":"Blakley","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","article-title":"Chemotherapy-induced alopecia","volume":"28","author":"Tr\u00fceb","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1288\/00005537-199007000-00008","article-title":"High-dose cisplatin treatment: Hearing loss and plasma concentrations","volume":"100","author":"Laurell","year":"1990","journal-title":"Laryngoscope"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MPH.0b013e3181b259a7","article-title":"Carnitine plasma levels and fatigue in children\/adolescents receiving cisplatin, ifosfamide, or doxorubicin","volume":"31","author":"Hockenberry","year":"2009","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814050-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:48Z","timestamp":1786647708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814050-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.188426","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}